Oestrogen receptor status, pathological complete response and prognosis in patients receiving neoadjuvant chemotherapy for early breast cancer
Open Access
- 23 November 2004
- journal article
- Published by Springer Nature in British Journal of Cancer
- Vol. 91 (12), 2012-2017
- https://doi.org/10.1038/sj.bjc.6602235
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Is Surgery Necessary After Complete Clinical Remission Following Neoadjuvant Chemotherapy for Early Breast Cancer?Journal of Clinical Oncology, 2003
- Correlation of Histologic Prognostic Factors in Core Biopsies and Therapeutic Excisions of Invasive Breast CarcinomaThe American Journal of Surgical Pathology, 2003
- Pathobiology of preoperative chemotherapyCancer, 2002
- Preoperative/neoadjuvant medical therapy for early breast cancerThe Lancet Oncology, 2001
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Neoadjuvant versus adjuvant chemotherapy in premenopausal patients with tumours considered too large for breast conserving surgery: Preliminary results of a randomised trial: S6European Journal Of Cancer, 1994
- Primary Chemotherapy To Avoid Mastectomy in Tumors With Diameters of Three Centimeters or MoreJNCI Journal of the National Cancer Institute, 1990
- In vitro adriamycin sensitivity test and hormonal receptors in primary breast cancerEuropean Journal of Cancer (1965), 1980
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- CARCINOMA OF THE BREAST*Annals of Surgery, 1943